Watch this closely at the bell. At eleven seconds prior to the market close on Friday this hit it's days high of 0.02 with a green 100 share signal transaction. Could be a mover and a shaker come Monday morning...........Nicodrops, Inc. 'NCDP' Goes Public With The Only Drug-Free Solution To Stop Smoking
Monday September 20, 6:30 am ET
Nicodrop's Nicotine Free Product Is The Only Product In The Market With No Known Side Effects
LA MESA, Calif.--(BUSINESS WIRE)--Sept. 20, 2004--Nicodrops, Inc. (PINK SHEETS:NCDP - News) announces that the Company has commenced trading on the OTCBB (Pink Sheet) under Symbol (NCDP). Nicodrops is moving into the public marketplace to aggressively pursue a significant market share of the global smoking cessation market with the First Non Nicotine, Drug-Free product.
Competing products such as Nicorette and Nicoderm contain nicotine to reduce the nicotine dependency and may not be used if an individual suffers from one or more of the following: heart attack, irregular heart beat, high blood pressure, thyroid problems, stomach problems, circulation disorder, heart disease, skin disease, allergies to drugs, stroke, kidney or liver disease, stomach ulcers, insulin dependency. Nicodrops' product is the only product in the market that does not have any known side effects.
The Product
Nicodrops, Inc. has developed a unique, non-nicotine based product designed to assist people who wish to stop smoking. Unlike its competitors, the product is drug free, faster acting and is less expensive.
The line of drug free smoking cessation products has been developed through a joint effort by National Group, National Healthcare Manufacturing Group, Mr. Christopher Calpito (Nicodrops CEO) and the Jamshidi Family. The product has been in development since 1994. National Group has embarked on an extensive program to research various natural herbal products that ultimately culminated the Nicodrops product line.
"We are excited about the opportunity before us" commented Christopher Calpito, President and Chief Executive Officer of Nicodrops, Inc. "While our competitors continue to use nicotine in their products, our lozenges offer a much safer and effective alternative as well as being less expensive" concluded Calpito.
The Market
The market for the Company's products is substantial. The market is comprised essentially of anyone who smokes anywhere in the world. Currently, if a smoker decides to give up the habit, the choices are to quit by using the "cold turkey" method or use one of a number of nicotine based products, which operate on a weaning principal. Nicodrops, Inc. product line provides the market with the only drug free smoking cessation product, which acts quicker and is less expensive than the competing Nicotine based products.
The Atlanta based Center for Disease Control estimates that 70 million or 24% of the entire population of the US are smokers. This translates into a market estimated at $700 Million annually in the United States alone. Projecting this on to the Company's global target markets results in a population of approximately 250 million people with a dollar value of $2.5 Billion.
Alliances with major retailers are expected in the months ahead.
About Nicodrops, Inc.
Nicodrops, Inc. was incorporated for the purpose of bringing to market a unique, drug free line of lozenge products designed to help people who wish to stop smoking. The Company has developed its smoking cessation product in consultation with certified research herbalists over a ten-year period. With the completion of the product development, Nicodrops is now positioned to capitalize on the research and development activities by introducing their products to the market place.
Nicodrops, Inc. ('Nicodrops' or the 'Company') was incorporated in 2002 under the laws of State of Pennsylvania and Province of Manitoba. Its head office is in La Mesa, California with its international offices in Winnipeg, Canada. The Company owns the proprietary recipes from which its products are produced.
-------------------------------------------
Nicodrops Announces European Community 'EC' Approval
Thursday September 23, 6:30 am ET
Assures Global Presence by Q-1 of 2005
LA MESA, Calif.--(BUSINESS WIRE)--Sept. 23, 2004--Nicodrops, Inc. (NCDP) today announced that it has formally received approval from the European Community (EC) to allow the company to distribute its proprietary products in the following 15 countries; UK, Ireland, Spain, Portugal, France, Germany, Italy, Greece, Belgium, Norway, Sweden, Denmark, Finland, Switzerland, and the Netherlands.
Nicodrops has now moved into the international marketplace to aggressively capture a significant share of the $2.5 Billion global market for smoking cessation products with the first non-nicotine, drug-free product with no known side effects.
Nicodrops will be manufactured and packaged in the UK or the Netherlands under licensing arrangements with Nicodrops, Inc. These manufacturing facilities will produce the finished lozenges from proprietary raw materials provided by the Company.
"We are quite pleased to add the EC market to the retail distribution being assembled in the US and Canadian markets" said Mr. Christopher Calpito, President and Chief Executive Officer of Nicodrops. "This addition of a Mega-Market like the EC" continued Mr. Calpito "brings us that much closer to our Threshold Corporate Objective ("TCO") of gaining a visible market share of the global market for smoking cessation products."
-------------------------------------
Nicodrops Announces Production of First and Only 'Sugar-Free' Smoking Cessation Lozenges Anywhere in the World!
Tuesday September 28, 6:30 am ET
LA MESA, Calif.--(BUSINESS WIRE)--Sept. 28, 2004--Nicodrops, Inc. (PINK SHEETS:NCDP - News) today announced that its Sugar Free Lozenge is now in production. "This will allow Nicodrops to compete in the $85 billion dollar Natural Living Market worldwide" Said Christopher Calpito "in 2005 and it is expected to increase by 30.7% in Europe alone" " continued Mr. Calpito. With negotiations in the Asian market very near to being finalized, the sugar free product arrives just in time. The Asian consumers tend to not like sweet products. Health conscious and Sugar-Free consumers including diabetics all over the world will now have a healthy, safe and quick method to stop smoking!
About Nicodrops, Inc.
Nicodrops, Inc. was incorporated for the purpose of bringing to market a unique, drug free line of lozenge products designed to help people who wish to stop smoking. The Company has developed its smoking cessation product over a ten-year period. With the completion of the product development, Nicodrops is now positioned to capitalize on the research and development activities by introducing their products to the market place.
Unlike its competitors, the product is drug free, acts faster and is less expensive. The product also assists those who wish to stop smoking without using the nicotine weaning process included in competing products. Introducing the drug-based products into the blood stream only heightens the risk of a heart attack if a person decides go back to smoking again. Nicodrops is a much safer and better product because it is drug-free and requires a much shorter time to show tangible results (less than 4 weeks compared to the drug based products that are 12 weeks or longer. Nicodrops lozenge is a no non-sense straightforward approach to begin a stop smoking program without using nicotine right from the onset. It will also assist smokers who cannot smoke during business hours. Nicodrops is a smoker's best ally in a smoker-unfriendly environment. It just might convert a smoker - somewhat inadvertently perhaps - into a non-smoker.
A thousand mile journey begins with that first step... "ancient Chinese Proverb"
---------------------------------------
The Cervelle Group Inks New Client for Investor Relations and Financial Communications Campaign
Tuesday November 16, 10:18 am ET
Orlando-Based Firm to Raise Visibility of Nicodrops, Inc.
ORLANDO, Fla., Nov. 16, 2004 (PRIMEZONE) -- The Cervelle Group, an investor relations/public relations company offering small- and mid-cap publicly held companies a range of investment, media and financial communications-related programs, announced today it has signed Nicodrops, Inc (Other OTC:NCDP.PK - News) as a client. The Cervelle Group will develop and provide Nicodrops with a comprehensive financial and media communications campaign targeting the U.S. and Canada.
``One of our main objectives is to help bring the NCDP story to the investment community while putting it in front our extensive retail broker network,'' said Rob M. Karbowsky, a managing partner of The Cervelle Group. ``In addition we look forward to working with Chris Calpito and his staff in their efforts to raise visibility, build momentum and increase the market advantages of Nicodrops in the public sector.''
Headquartered in Orlando, FL, The Cervelle Group delivers results-based solutions in the areas of emerging- and established-company investor relations, public relations, media relations, crisis communications, e-business/Internet and marketing communications.
Nicodrops Inc., headquartered in La Mesa, CA, has developed the world's first drug-free, non-nicotine product which allows smokers to give up their habit faster and at a lower cost than their major competitors without the adverse side effects of nicotine. Nicodrops is an all-natural herb lozenge which helps to calm the nervous anxiety that is brought on by nicotine addiction. The company's lozenge products are based on patent protected proprietary technology which offers a safer alternative to all other nicotine based products in the marketplace today.
------------------------------
Nicodrops Inc. Announces Canadian FDA Approval of its Smoking Cessation Lozenges
Wednesday December 1, 9:06 am ET
LA MESA, Calif., Dec. 1, 2004 (PRIMEZONE) -- Nicodrops, Inc. (Other OTC:NCDP.PK - News), developer of the world's first drug-free, non-nicotine smoking cessation lozenge, announced today it has formally received approval from the Canadian Food and Drug Administration for their smoking cessation lozenge. The Canadian FDA Approval Drug Identification Number (DIN) 00245097 was issued through the Therapeutic Products Directorate of the Health Canada, FDA. The DIN number now permits Nicodrops to sell its products in the Canadian market
``Canadian FDA approval gives us access to the vast number of smokers who are looking for an effective solution to quit smoking throughout Canada which, when combined with the U.S. smoking population, gives us a very attractive market of about 77 million smokers,'' said Christopher Calpito, president and CEO of Nicodrops, Inc. ``Nicodrops will be the only drug free smoking cessation lozenge with little or no side effects to be offered in Canada, this gives us a decided edge over our competition.
``We plan on taking advantage of the aggressive anti-smoking campaigns currently taking place in U.S. and Canada by promoting Nicodrops as the lower priced, faster acting drug free solution to quit smoking.''
Recently, Nicodrops announced it has formally received approval from the European Community (EC) to allow the company to distribute its proprietary products in the following 15 countries; UK, Ireland, Spain, Portugal, France, Germany, Italy, Greece, Belgium, Norway, Sweden, Denmark, Finland, Switzerland, and the Netherlands.
In addition, Nicodrops lozenge products are in the ``Dietary Supplements'' category for purposes of the United States market so it doesn't require FDA approval according to Calpito. Nicodrops products are governed by the Dietary Supplemental Health and Education Act.
---------------------------------------------
Nicodrops Inc. Announces New Director Of Sales To Advisory Board
Thursday December 9, 8:00 am ET
Company Names Joel Appel, Former Slim-Fast Marketing Guru
LA MESA, Calif., Dec. 9, 2004 (PRIMEZONE) -- Nicodrops, Inc. (Other OTC:NCDP.PK - News), developer of the world's first drug-free, non-nicotine smoking cessation lozenge, announced that they have selected Joel Appel, best known for his work with Ultra Slim-Fast, as new Director of Sales and marketing for NCDP. Mr. Appel will also sit on the Nicodrops Advisory Board. Mr. Appel was selected not only for his reputation in the industry for putting Slim-Fast on the map but his vast knowledge of product placement and advertising to maximize all markets. To date, Mr. Appel has been working as a consultant for a number of mainstream retail-oriented products.
Mr. Appel brings to NCDP many years of experience in sales and marketing of OTC brands. He began his career at Proctor & Gamble serving in the position of Territory Manager, Unit Manager and District Manager. While at Proctor & Gamble, Mr. Appel introduced Pampers Disposable Diapers and won an award for selling the most disposable diapers in the United States. During the 70's, 80's and 90's Mr. Appel was involved in sales and marketing of some very familiar brands, Oxy 5, Tums, Aqua Net and Orajel, just to name a few. During the early 80's he was Senior Executive VP at Jeffrey Martin where he served on the Board of Directors. In the late 80's, Mr. Appel held the position of Senior VP of Sales with Thompson Medical where he was part of the team that introduced Ultra Slim-Fast. More recently Mr. Appel held the position of Senior VP of Sales with GenDerm Health Care. While at GenDerm he helped reposition ZOSTRIX and ZOSTRIX-HP from ethically promoted and positioned products to consumer (OTC) products. The brand grew from 6 million to over 20 million dollars in sales in less than two years.
``To bring someone of the caliber of Joel Appel on board demonstrates the vast potential of our product,'' said Christopher Calpito, president and CEO of Nicodrops, Inc. ``His experience and industry contacts when it comes to marketing a product such as Nicodrops is beyond reproach. With Joel's assistance, we plan on taking full advantage of the aggressive anti-smoking campaigns currently taking place in the U.S, Europe and Canada by promoting Nicodrops as the lower priced, faster acting drug free solution to quit smoking.''
Recently, Nicodrops announced it has formally received approval from the Canadian equivalent of the US FDA(1) the European Community (EC) to allow the company to distribute its proprietary products in the following 16 countries; Canada, UK, Ireland, Spain, Portugal, France, Germany, Italy, Greece, Belgium, Norway, Sweden, Denmark, Finland, Switzerland, and the Netherlands.
Note(1)(Correction the Canadian DIN number should have been DIN 02245097)
In addition, Nicodrops lozenge products are in the ``Dietary Supplements'' category for purposes of the United States market so it doesn't require FDA approval according to Calpito. Nicodrops products are governed by the Dietary Supplemental Health and Education Act.
---------------------------------------
Nicodrops Featured on CEO Webcast
Friday December 10, 2:39 pm ET
LA MESA, Calif., Dec. 10, 2004 (PRIMEZONE) -- Nicodrops, Inc. (Other OTC:NCDP.PK - News), announced today that Chris Calpito, CEO of Nicodrops, Inc., has conducted a CEO Webcast so that NCDP shareholders and the investment community can learn more about the current and future prospects of Nicodrops, Inc. The webcast is conducted by Evergreen Marketing, Inc. and will be available on Tuesday, December 14th to the general public on The Green Baron Investors Society's website at http://www.*************.com
Headquartered in La Mesa, CA, Nicodrops, Inc. has developed the very first drug-free, non-nicotine product which allows smokers to give up their habit faster and at a lower cost than their major competitors without the adverse side effects of nicotine. Nicodrops is an all-natural herb lozenge which helps to calm the nervous anxiety that is brought on by nicotine addiction. The company's lozenge products are based on patent protected proprietary technology which offers a safer alternative to all other nicotine based products in the marketplace today.
The company has some exciting new developments to discuss with shareholders and interested investors. According to Calpito, ``This CEO Webcast is being presented to get investors and the public in general excited about Nicodrops unique herbal product to help smokers quit and to share the dramatic change in direction our company is about to take.''
The CEO Webcast with Mr. Chris Calpito of Nicodrops, Inc. is conducted by Evergreen Marketing, Inc. and their subsidiary The Green Baron Investors Society. For more information about Evergreen Marketing, Inc. and their subsidiary The Green Baron Investors Society visit them on the web at http://www.EvergreenMarketingInc.com and http://www.*************.com.
_________________________________________________________________
Both the Average Volume and the Moving Average were up over 20% compared to the best it had seen the past 60 days. The past five days it has been picking up steam in both areas..........Keep a very very close eye on this in the morning!!!!! Ruff!!!!!
------------------
Whoever is first in the field and awaits the coming of the enemy, will be fresh for the fight; whoever is second in the field and has to hasten to battle will arrive exhausted.
The Art Of War - Sun Tzu
"Do Da Due - But Be Damn Quick About It"
Da Art Of Daytrading - Dardadog
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
